日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Can serum biomarkers predict the outcome of systemic immunosuppressive therapy in adult atopic dermatitis patients?

血清生物标志物能否预测成人特应性皮炎患者接受全身免疫抑制治疗的疗效?

Hurault, G; Roekevisch, E; Schram, M E; Szegedi, K; Kezic, S; Middelkamp-Hup, M A; Spuls, P I; Tanaka, R J

Effect of immunosuppressive treatment on biomarkers in adult atopic dermatitis patients.

免疫抑制治疗对成人特应性皮炎患者生物标志物的影响

Roekevisch E, Szegedi K, Hack D P, Schram M E, Res P C J M, Bos J D, Leeflang M M G, Luiten R M, Kezic S, Spuls P I, Middelkamp-Hup M A

Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME)

关于协调特应性湿疹/皮炎临床试验核心结果指标的第三次国际共识会议(HOME)的报告

Chalmers, J R; Schmitt, J; Apfelbacher, C; Dohil, M; Eichenfield, L F; Simpson, E L; Singh, J; Spuls, P; Thomas, K S; Admani, S; Aoki, V; Ardeleanu, M; Barbarot, S; Berger, T; Bergman, J N; Block, J; Borok, N; Burton, T; Chamlin, S L; Deckert, S; DeKlotz, C C; Graff, L B; Hanifin, J M; Hebert, A A; Humphreys, R; Katoh, N; Kisa, R M; Margolis, D J; Merhand, S; Minnillo, R; Mizutani, H; Nankervis, H; Ohya, Y; Rodgers, P; Schram, M E; Stalder, J F; Svensson, A; Takaoka, R; Teper, A; Tom, W L; von Kobyletzki, L; Weisshaar, E; Zelt, S; Williams, H C